Global Hand, Foot, and Mouth Disease Treatment Market - Introduction
Hand, foot, and mouth disease (HFMD) is a contagious viral infection. It is a mild clinical syndrome, which mostly affects infants and children. It can be cured within 7 to 10 days. The most common causative agents of hand, foot, and mouth disease are coxsackievirus A16 and enterovirus A71. A supportive treatment is generally recommended for hand, foot, and mouth disease. The disease is characterized by oral enanthem, maculopapular, and macular or vesicular rashes on the hands and feet. The virus causes rashes or blisters in the mouth and on the palms of hands, soles of feet, and blisters in the mouth at the back of throat.
Global Hand, Foot, and Mouth Disease Treatment Market - Competitive Landscape
The global hand, foot, and mouth disease market is fragmented, with large number of domestic players holding majority shares in respective regions. The global market is attracting large number of domestic manufacturers. Major players operating in the global hand, foot, and mouth disease treatment market focus on business expansion, research & development, and mergers & collaborations.
Need an Overview of the Report on Hand, Foot, and Mouth Disease Treatment Market? Ask for the Brochure here
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. is a key producer of generic medicines and a recognized leader in innovative and specialty pharmaceuticals across the globe. The company delivers high quality and patient-centric health care solutions across the globe. It has a broad generic product portfolio, with more than 35,000 products in nearly every therapeutic area. Teva Pharmaceutical Industries operates through two business segments: generic medicines and specialty medicines.
Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited is an innovation-driven global pharmaceutical company engaged in the research & development, manufacture, and marketing of novel therapeutic drugs. The company offers its products in three therapeutic areas: gastroenterology, oncology, and central nervous system. Moreover, Takeda Pharmaceutical Company develops vaccines for prevention of various infectious diseases. The company has more than 18 manufacturing sites globally and 151 subsidiary companies.
Global Hand, Foot, and Mouth Disease Treatment Market - Dynamics
Increase in Footprint of Pharmaceutical Companies in Emerging Markets
Availability of cost-effective drugs across the globe and increase in footprint of pharmaceutical manufacturers in potential markets in Asia Pacific, Latin America, and Middle East & Africa are expected to propel the global hand, foot, and mouth disease treatment market.
Stuck in a Neck-to-Neck Competition with other Brands? Request a Custom Report on “Hand, Foot, and Mouth Disease Treatment Market” here
Research & Development of Drugs and Vaccines to Drive Market
A large number of promising novel drug candidates are in different stages of clinical trials. The anticipated approvals of novel agents such as molecular decoys, translation inhibitors, receptor antagonists, and replication inhibitors are expected to propel the global hand, foot, and mouth disease treatment market during the forecast period. Rise in health care expenditure drives demand for research & development of biologics and biosimilars for treatment of hand, foot, and mouth disease.
High Prevalence of Viral Infection Causing Hand, Foot, and Mouth Disease to Propel Market
An article published by NCBI stated that 3,605 to 9,271 cases of HFMD were reported in the Republic of Korea between 2010 and 2014, with prevalence of 1 in 3 deaths. Moreover, the socioeconomic burden ranged from US$ 80.5 Mn to US$ 164.2 Mn.
However, stringent government regulations for sale of over-the-counter hand, foot, and mouth disease drugs and lack of awareness about the disease in developing countries are likely to restrain the global hand, foot, and mouth disease treatment market.
Global Hand, Foot, and Mouth Disease Treatment Market - Segmentation
In terms of drug type, the global hand, foot, and mouth disease treatment market can be classified into:
- Pain Relievers
- Nucleoside Analogue Antivirals
- Non-steroidal Anti-inflammatory Drugs
Based on distribution channel, the global hand, foot, and mouth disease treatment market can be divided into:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.